Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones [PDF]
Chinese hamster ovary (CHO) cells are by far the most commonly used mammalian expression system for recombinant expression of therapeutic proteins in the pharmaceutical industry.
Wenwen Yang +8 more
doaj +2 more sources
Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. [PDF]
Genome sequences of the Chinese hamster and six Chinese hamster ovary cell lines provide a resource to aid in improving production of recombinant proteins.
Baycin-Hizal, Deniz +20 more
core +3 more sources
4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture. [PDF]
There is a continuous demand to improve monoclonal antibody production for medication supply and medical cost reduction. For over 20 years, recombinant Chinese hamster ovary cells have been used as a host in monoclonal antibody production due to ...
Yuichi Aki +4 more
doaj +2 more sources
Chinese hamster ovary cell line DXB-11: chromosomal instability and karyotype heterogeneity [PDF]
Background Chinese hamster ovary cell lines, also known as CHO cells, represent a large family of related, yet quite different, cell lines which are metabolic mutants derived from the original cell line, CHO-ori.
Victoria I. Turilova +2 more
doaj +2 more sources
Genetic drivers of Chinese hamster ovary cell proliferation revealed by functional genomics [PDF]
Summary: Cell lines used in biopharmaceutical manufacturing are engineered to optimize protein yield, quality, and production speed. Cellular growth rate is a key bottleneck in the development of biopharmaceutical production cell lines.
Jannis Marzluf +4 more
doaj +2 more sources
Comparative omics profiling reveals differences in biomass, energy production, and vesicle transport between CHO and fast-growing CHL-YN cells [PDF]
Chinese hamster lung (CHL)-YN cells are promising novel hosts for producing therapeutic antibodies with the potential to shorten the research, development, and manufacturing timelines in biopharmaceutical production.
Yu Tsunoda +6 more
doaj +2 more sources
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. [PDF]
The Chinese hamster ovary (CHO) cell line is a well-established platform for the production of biopharmaceuticals due to its ability to express complex therapeutic proteins with human-like glycopatterns in high amounts. The advent of CRISPR technology has opened up new avenues for the engineering of CHO cell lines for improved protein production and ...
Glinšek K, Bozovičar K, Bratkovič T.
europepmc +3 more sources
Glycoengineering Chinese hamster ovary cells: a short history [PDF]
Biotherapeutic glycoproteins have revolutionised the field of pharmaceuticals, with new discoveries and continuous improvements underpinning the rapid growth of this industry. N-glycosylation is a critical quality attribute of biotherapeutic glycoproteins that influences the efficacy, half-life and immunogenicity of these drugs.
Roberto Donini +2 more
openaire +4 more sources
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Recombinant monoclonal antibodies bind specific molecular targets and, subsequently, induce an immune response or inhibit the binding of other ligands. However, monoclonal antibody functionality and half-life may be reduced by the type and distribution of host-specific glycosylation. Attempts to produce superior antibodies have inspired the development
Marbiah, M +7 more
openaire +4 more sources
Proteomic Analysis of Chinese Hamster Ovary Cells [PDF]
To complement the recent genomic sequencing of Chinese hamster ovary (CHO) cells, proteomic analysis was performed on CHO cells including the cellular proteome, secretome, and glycoproteome using tandem mass spectrometry (MS/MS) of multiple fractions obtained from gel electrophoresis, multidimensional liquid chromatography, and solid phase extraction ...
Deniz, Baycin-Hizal +17 more
openaire +2 more sources

